Status:
COMPLETED
Pea Protein Supplementation and Muscle Damage
Lead Sponsor:
Appalachian State University
Collaborating Sponsors:
Roquette Freres
Conditions:
Muscular Injury
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if supplementation with NUTRALYS pea protein isolate compared to whey protein and apple juice (carbohydrate, non-protein control) before, during, and after a ...
Detailed Description
Study participants will be randomized to the NUTRALYS pea protein supplement, whey protein, or apple juice (parallel group design). Study participants will come to the lab at 7:00 am Monday through Fr...
Eligibility Criteria
Inclusion
- Male, female, 18 to 55 years of age.
- Non-athlete, and not engaged in regular resistance training (less than 3 sessions per week).
- BMI under 30 (non-obese).
- At "low risk" status for cardiovascular disease (as determined with a screening questionnaire).
- Agree to avoid the use of protein and large-dose vitamin/mineral supplements (above 100% of recommended dietary allowances), herbs, and all medications (in particular, NSAIDs such as ibuprofen and aspirin) during the week of the project.
Exclusion
- Inability to comply with study requirements.
- Any other concurrent condition which, in the opinion of the primary investigator (PI), would preclude participation in this study or interfere with compliance.
- Current, active history of coronary heart disease, stroke, cancer, diabetes, rheumatoid arthritis, high blood pressure, kidney disease, liver disease, blood disease, hormonal disease, or metabolic disease.
- History of cancer in the 5 years prior to the screening visit (except skin or cervical cancer that was successfully treated).
- Current use of any type of medication (or unwillingness to stop use of over-the-counter medications two weeks before the start of the study).
- Recent history of musculoskeletal trauma (fracture, strain, sprain, etc.) that has not fully healed prior to baseline testing.
- Females: pregnant or breastfeeding; or body weight under 100 pounds.
Key Trial Info
Start Date :
March 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03448328
Start Date
March 5 2018
End Date
June 1 2020
Last Update
July 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Appalachian State University Human Performance Lab, North Carolina Research Campus
Kannapolis, North Carolina, United States, 28081